Search
Search results
VG801 gene therapy shows early promise for Stargardt disease in phase 1/2 clinical trial
VeonGen has reported encouraging early results from a clinical trial of VG801, an investigational gene therapy for Startgardt disease, a genetic retinal condition that currently has no approved treatments.
Information and support
Are you affected by inherited sight loss? We are here to help.
What we do
Our vision is a world where everyone with inherited sight loss is able to live a fulfilling life.
Family planning
If you, or a close relative, are living with a genetic sight loss condition, there may be a chance that your children will inherit it.
Meet a Researcher: Dr Nikolas Pontikos
Dr Nikolas Pontikos is a Senior Research Fellow at UCL Institute of Ophthalmology, and has been working on inherited retinal conditions for several years.
The Kiltwalk 2027 (Dundee)
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2027.
The Kiltwalk 2027 (Aberdeen)
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2027.
The Kiltwalk 2027 (Edinburgh)
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2027.
Discover Wellbeing
We have created Discover Wellbeing to help people affected by inherited sight loss to develop an awareness of emotional wellbeing and the practical skills to adapt to life’s ups and downs.